INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 422m ago
HOUSE PTR22m ago
SEC 13F22m ago
ROBINHOOD CHAIN22m ago
Corporate insider
SL

Sing George L

DirectorCIK 0001225471

EDGAR filingsOpen in network
Disclosed transactions13
Buys / sells0 / 9
Max Insider Score48
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
44
SL
Sing George LDirector
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale
SELL$2.43M
2,522 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    REGENERON PHARMACEUTICALS, INC.Director · Nov 4, 2026
44
SL
Sing George LDirector
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale
SELL
$4.18M
4,338 sh
Nov 2, 2026
Nov 4, 2026
traded Nov 2, 2026
+2d
SEC FORM 4

Evidence

44
SL
Sing George LDirector
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale
SELL$2.58M
2,670 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

44
SL
Sing George LDirector
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale
SELL$1.47M
1,522 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

40
SL
Sing George LDirector
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale
SELL$1.01M
1,040 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

9
SL
Sing George LDirector
REGNREGENERON PHARMACEUTICALS, INC.
Option exercise
M—
7,830 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

9
SL
Sing George LDirector
REGNREGENERON PHARMACEUTICALS, INC.
Option exercise
M—
7,439 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

26
SL
Sing George LDirector
REGNREGENERON PHARMACEUTICALS, INC.
Option exercise
M$2.95M
7,830 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

22
SL
Sing George LDirector
REGNREGENERON PHARMACEUTICALS, INC.
Option exercise
M$2.83M
7,439 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

40
SL
Sing George LDirector
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale
SELL$1.18M
1,224 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

37
SL
Sing George LDirector
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale
SELL$519K
540 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

48
SL
Sing George LDirector
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale
SELL$6.83M
7,073 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence

34
SL
Sing George LDirector
REGNREGENERON PHARMACEUTICALS, INC.
Open-market sale
SELL$194K
200 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC FORM 4

Evidence